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This study used published mortality data and regression techniques to look at time trends in cervical cancer mortality between 1970
and 2000 in the UK and the Republic of Ireland. Mortality from cancer of the cervix has been declining in the UK for at least the past
30 years. The rate of decrease has been greatest in England, Wales and Scotland and has accelerated in these countries since the
reorganisation of screening services in the late 1980s. Mortality in Northern Ireland is also decreasing, but at a lesser rate and without
significant change over the same period. In contrast, cervical cancer mortality in the Irish Republic, which, unlike the UK, does not have
comprehensive population-based screening, has been increasing by an average of 1.5% per year since 1978. The mortality rate, which
was half of that in the UK in the late 1970s, now exceeds that in any of the region of the UK. The absence of population-based
screening for cervical cancer in the Republic of Ireland is the most plausible explanation for these differences in trend.
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Population-based cervical screening programmes have been shown
to be effective in reducing morbidity and mortality from cervical
cancer (Laara et al, 1987; Anderson et al, 1988; Hakama and
Louhivuori, 1988). Different mortality trends in Nordic countries
have been ascribed to the ways in which cervical screening was
delivered (Laara et al, 1987; Hakama and Louhivuori, 1988). While
Iceland, Finland, Sweden and parts of Denmark achieved almost
complete coverage of the target populations, resulting in sharp falls
in incidence and mortality, Norway did not have an organised
screening programme and the risk of invasive cancer continued to
rise into the late 1970s.
Opportunistic screening, with recall of those who previously had
a smear, began in Britain in 1964 (Cancer Research UK, 2003).
However, in England prior to 1988, at least two-thirds of patients
with invasive cancer had never been screened and in those aged
over 40 years (70% of cases), 90% had never been screened (Cancer
Research UK, 1994). In the UK, the 1987 recommendation of the
Intercollegiate Working Party (Intercollegiate Working Party on
Cervical Cytology Screening, 1987) recommended population
screening and by 1991 all District Health Authorities operated
population screening on either a 3 or 5 yearly basis. Coverage of
women in the target age range had increased from 43% in 1988/9
to 83% in 1992/3 (Cervical Screening Programme England 2001–
02, 2002). In contrast, in the Republic of Ireland, although there is
a high level of opportunistic screening (Department of Health and
Children, 2003), the only population-based screening is a small
pilot project in the MidWestern Health Board, covering 9% of the
national population (Irish Cervical Screening Project, 2003).
This study compares trends in cervical cancer mortality between
1970 and 2001 in Ireland, Northern Ireland, Scotland, England and
Wales, and investigates differences in rates and trends, which
might be attributable to population-based screening.
MATERIALS AND METHODS
Official mortality statistics were examined for all the regions from
1971 to the most recent available date. The JoinPoint Regression
Programme, developed at the National Cancer Institute (JoinPoint
Regression Program, 2000), was used to fit linear regression lines
to the age-standardised (World population) mortality rates and to
identify points of inflection. Variances for each point were
calculated from the number of observed deaths.
RESULTS
In 1971, mortality from cancer of the cervix in Britain was much
higher than in Ireland and slightly higher in Northern Ireland than
in the Republic (Table 1). However, between 1971 and 2000,
mortality in Britain dropped dramatically, especially after 1989,
and that in Northern Ireland more slowly, while that in Ireland did
not. As a result, by 2000, cervical cancer mortality in the Republic
of Ireland exceeded that in all the other regions. In England, Wales
and Scotland, the mortality rate for women age 20–34 years halved
between 1986 and 2000–2001. No trend was apparent in Ireland,
and the numbers were too small to draw any conclusion
concerning Northern Ireland. However, the numbers in this age
group were too small to have any effect on overall trends.
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Wales and Scotland to be almost identical. In England and Wales,
mortality rates fell slowly before 1988, with an estimated annual
percentage decrease of 1.0% with 95% confidence intervals (CI) of
0.7–1.2%, but after 1988 the rate of decrease was much greater,
4.6% per annum (95% CI 4.2–5.0%). In Scotland, the rate of
decrease went from 1.0% per annum (95% CI 0.4–1.6%) before
1989 to 4.2% (2.9–5.5%) after that date. In Northern Ireland, there
was a small but steady decrease in mortality over the period 1971–
2000, with an annual rate of decrease of 1.8% (95% CI 1.0–2.6%),
but no observable point of inflection.
In the Republic of Ireland, the pattern was quite different. Prior
to 1978, cervical cancer mortality fell by an estimated 3.9% per
year (95% CI 1.0–8.7%), but this trend reversed to give a steady
increase of 1.5% per annum (95% CI 0.6–2.3%) up to 2001. The
model suggests that this trend will continue into the near future.
DISCUSSION
In England, Scotland and Wales, mortality from cancer of the
cervix has been declining since 1970, as reported previously
(Quinn et al, 1999). These long-term trends in death rates have
brought mortality in England, Scotland and Wales below that in
the Republic of Ireland for the first time. If current trends
continue, mortality rates in Northern Ireland also look likely to
exceed those in the rest of the UK in the near future. The reduction
in deaths up to 1997 in England due to screening has been
estimated at 800 (Quinn et al, 1999), 1300 (Sasieni and Adams,
1999) or 2000 (Quinn et al, 1999; Peto et al, 2004).
Cervical cancer mortality in Northern Ireland has historically
been lower than in Britain. The impact of population-based
screening in the past two decades seems lower than that in Britain
and, although mortality is steadily falling, the more rapid rate of
decrease seen in the rest of the UK in the 1990s has not happened
in Northern Ireland. However, the data for Northern Ireland are
sparse and an acceleration in the decline of mortality in the late
1980s may be concealed within the random variation. On the other
hand, cervical cancer mortality in the Republic of Ireland has
increased steadily throughout the 1980 and 1990s and looks like
continuing this trend into this decade. As the number of deaths
registered as due to cancer of the uterus (part unspecified) has
remained low throughout this period (Central Statistics Office,
1974, 2002), changes in death registration practice seem an
unlikely explanation for the trend. Assuming that the trend is
real, there are two possible, but not mutually exclusive, explana-
tions for the increase – the incidence of cervical cancer may be
increasing or survival may be worsening. Data from the National
Cancer Registry (National Cancer Registry, 2003) show that the
Table 1 Average annual age-standardised mortality from cancer of the cervix in Britain and Ireland (1971–2000)
Annual age-standardised mortality rates (number of deaths)
Year of death England and Wales N. Ireland Scotland Ireland
All ages
1971–75 5.7 (10993) 4.6 (227) 5.7 (1151) 3.7 (344)
1976–80 5.4 (10659) 3.3 (172) 5.3 (1053) 2.8 (270)
1981–85 5.0 (9849) 3.6 (182) 5.2 (1056) 2.9 (300)
1986–90 4.7 (9450) 3.4 (184) 4.7 (945) 3.1 (331)
1991–95 3.5 (7509) 2.9 (161) 4.0 (829) 3.0 (288)
1996–99 2.7 (4805) 2.8 (140) 3.0 (549) 3.3 (335)
2000–01 1.6 (2145) 2.3 (54) 2.6 (230) 3.9 (322)
Women aged 20–34 years
1971–75 1.1 (271) 0.4 (3) 0.9 (22) 0.9 (12)
1976–80 1.6 (437) 1.3 (10) 1.3 (36) 0.6 (11)
1981–85 2.0 (576) 1.5 (13) 1.9 (57) 1.1 (23)
1986–90 2.0 (582) 1.1 (10) 2.3 (69) 0.7 (15)
1991–95 1.4 (445) 0.7 (7) 1.3 (40) 0.7 (17)
1996–99 1.1 (272) 1.4 (12) 1.0 (27) 1.0 (15)
2000–01 0.9 (120) 0.4 (2) 1.1 (12) 1.0 (19)
Women aged 35 years and over
1971–75 14.3 (10722) 11.8 (224) 14.4 (1129) 9.3 (332)
1976–80 13.4 (10222) 7.9 (162) 13.2 (1017) 7.1 (259)
1981–85 11.9 (9273) 8.7 (169) 12.5 (999) 6.9 (277)
1986–90 11.3 (8868) 8.2 (174) 11.1 (876) 7.8 (316)
1991–95 8.4 (7064) 7.2 (154) 9.7 (789) 7.7 (271)
1996–99 6.4 (4533) 6.5 (128) 7.3 (522) 8.4 (320)
2000–01 4.0 (2025) 5.7 (52) 6.1 (218) 8.4 (303)
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Figure 1 Modelled trends in cervical cancer mortality in Britain and
Ireland (1971–2001).
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between 1994 and 1999, but no incidence information is available
for the period before 1994. It is possible, although unlikely, that the
trend may have been in the opposite direction in the 1980s and
1990s. Major changes in sexual behaviour seem to have occurred
during that time, as evidenced by an increase in the percentage of
births outside marriage from 5% (1980) to 30% (Central Statistics
Office, 2002) and in sexually transmitted infection, including a ten-
fold increase in the incidence of anogenital warts between 1989 and
2000 (National Disease Surveillance Centre, 2001). However,
similar changes have occurred in the UK without a corresponding
increase in cervical cancer mortality (Peto et al, 2004).
The second possibility is of a decrease in survival, although this
seems unlikely in view of the general increase in cervical cancer
survival throughout Europe during this period (Coleman et al,
2003). The most probable explanation is that in Ireland, unlike the
UK, an increase in cervical cancer incidence has not been offset by
the improvement in detection of precancerous lesions, and so
survival, brought about by screening (Peto et al, 2004). Early
detection through effective screening is a major factor in
improving survival. Screening activity in Ireland can be measured
only through the number of smears processed in public
laboratories, which was over 180000 in 2000 (Department of
Health and Children, 2003). If all women in the target group were
having regular screening, this volume of activity would equate,
over a 3-year period, to 61% coverage of the female population
aged 25–59 years. However, no information is available on the
ages of women screened, nor on their screening history, so women
of the wrong age, or those with recent negative tests, may make up
a significant proportion of the total.
The experience of the Nordic countries and of British Columbia
(Laara et al, 1987; Anderson et al, 1988; Hakama and Louhivuori,
1988) suggests that only those with an organised population-based
programme show significant decreases in mortality. Although
deaths from cervical cancer are relatively infrequent in Ireland
(76 per year on average; 2.2% of all cancer deaths), they are
largely preventable through screening. The opportunistic
screening at present carried out in Ireland appears to be having
little impact on the overall rate of mortality from cervical cancer.
A move from the current system to a population-based programme
would not greatly increase the volume of screening while
probably bringing about the type of mortality reduction seen
elsewhere.
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